NEW YORK (GenomeWeb News) – Gen-Probe is targeting a 2011 launch in the US for its molecular diagnostic assay for human papillomavirus, CFO Herm Rosenman told investors Wednesday afternoon at the UBS Global Life Sciences Conference.

The San Diego-based firm received the CE Mark and launched the Aptima HPV Assay in Europe in May. The test runs on its Tigris instrument system, which Rosenman said is the only fully automated molecular diagnostics instrument on the market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.